Detection of bladder cancer recurrence by microsatellite analysis of urine

被引:221
作者
Steiner, G [1 ]
Schoenberg, MP [1 ]
Linn, JF [1 ]
Mao, L [1 ]
Sidransky, D [1 ]
机构
[1] JOHNS HOPKINS UNIV, SCH MED, DEPT OTOLARYNGOL HEAD & NECK SURG, DIV HEAD & NECK CANC RES, BALTIMORE, MD 21205 USA
关键词
D O I
10.1038/nm0697-621
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A reliable, noninvasive method for monitoring patients with transitional cell carcinoma (TCC) of the bladder would be of great clinical benefit. Cystoscopy is currently the ''gold standard,'' but it is invasive, expensive and uncomfortable for the patient. Recently, we demonstrated a novel approach for the detection of primary bladder cancer based on microsatellite analysis of urine DNA. To determine the feasibility of this technique for following-up patients with TCC, we tested serial urine samples from 21 patients who had been treated for bladder cancer with 20 polymorphic microsatellite markers in a blinded fashion. We detected recurrent lesions in 10 out of 11 patients and correctly predicted the existence of a neoplastic cell population in the urine of two patients, 4 and 6 months before cystoscopic evidence of the tumor. The assay was negative in 10 of 10 patients who had no evident cancer. Microsatellite analysis of urine sediment represents a novel and potentially powerful clinical tool for the detection of recurrent bladder cancer.
引用
收藏
页码:621 / 624
页数:4
相关论文
共 16 条
[11]  
2-G
[12]   URINE SEDIMENT SMEARS AS A DIAGNOSTIC PROCEDURE IN CANCERS OF THE URINARY TRACT [J].
PAPANICOLAOU, GN ;
MARSHALL, VF .
SCIENCE, 1945, 101 (2629) :519-520
[13]   ANCHORAGE DEPENDENCE, INTEGRINS, AND APOPTOSIS [J].
RUOSLAHTI, E ;
REED, JC .
CELL, 1994, 77 (04) :477-478
[14]   RESULTS OF A MULTICENTER TRIAL USING THE BTA TEST TO MONITOR FOR AND DIAGNOSE RECURRENT BLADDER-CANCER [J].
SAROSDY, MF ;
WHITE, RWD ;
SOLOWAY, MS ;
SHEINFELD, J ;
HUDSON, MA ;
SCHELLHAMMER, PF ;
JAROWENKO, MV ;
ADAMS, G ;
BLUMENSTEIN, BA .
JOURNAL OF UROLOGY, 1995, 154 (02) :379-383
[15]   Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment [J].
Soloway, MS ;
Briggman, JV ;
Carpinito, GA ;
Chodak, GW ;
Church, PA ;
Lamm, DL ;
Lange, P ;
Messing, E ;
Pasciak, RM ;
Reservitz, GB ;
Rukstalis, DB ;
Sarosdy, MF ;
Stadler, WM ;
Thiel, RP ;
Hayden, CL .
JOURNAL OF UROLOGY, 1996, 156 (02) :363-367
[16]  
WANG Y, IN PRESS J ELECTROPH